Rep. Cleo Fields Buys Quantinuum Inc. (NASDAQ:QNT) Stock

Representative Cleo Fields (Democratic-Louisiana) recently bought shares of Quantinuum Inc. (NASDAQ:QNT). In a filing disclosed on June 26th, the Representative disclosed that they had bought between $1,001 and $15,000 in Quantinuum stock on June 4th. The trade occurred in the Representative’s “MORGAN STANLEY – E*TRADE #2” account.

Representative Cleo Fields also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Alphabet (NASDAQ:GOOG) on 6/15/2026.
• Purchased $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 6/11/2026.
• Purchased $1,001 – $15,000 in shares of Apple (NASDAQ:AAPL) on 5/14/2026.
• Purchased $1,001 – $15,000 in shares of Taiwan Semiconductor Manufacturing (NYSE:TSM) on 4/9/2026.

Quantinuum Trading Up 1.2%

NASDAQ QNT traded up $0.88 during trading hours on Tuesday, hitting $73.72. The company’s stock had a trading volume of 668,962 shares, compared to its average volume of 4,149,317. Quantinuum Inc. has a 12 month low of $50.10 and a 12 month high of $81.48.

Insider Activity

In other news, Director Manish H. Bhatia bought 20,000 shares of the stock in a transaction that occurred on Friday, June 5th. The shares were bought at an average price of $60.00 per share, for a total transaction of $1,200,000.00. Following the purchase, the director owned 25,833 shares in the company, valued at $1,549,980. This represents a 342.88% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this link. Also, Director Paul R. Daugherty bought 4,000 shares of the stock in a transaction dated Friday, June 5th. The stock was bought at an average cost of $60.00 per share, for a total transaction of $240,000.00. Following the acquisition, the director directly owned 9,833 shares of the company’s stock, valued at approximately $589,980. This represents a 68.58% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders purchased 411,032 shares of company stock worth $24,661,920.

Key Quantinuum News

Here are the key news stories impacting Quantinuum this week:

• Positive Sentiment: Quantinuum received multiple fresh upgrades to “strong-buy” from Cantor Fitzgerald, Evercore, and Jefferies, signaling rapidly improving analyst sentiment. The Fly
• Positive Sentiment: Several major firms initiated or reiterated bullish coverage, including JPMorgan (overweight, $97 target), Rosenblatt (buy, $155 target), Bank of America (buy, $100 target), Needham (buy, $100 target), Mizuho (outperform, $90 target), Craig Hallum (buy, $100 target), and Sanford C. Bernstein (outperform, $94 target). Benzinga
• Neutral Sentiment: One new initiation was more cautious: Morgan Stanley started coverage with an equal weight rating and a $78 target, indicating some upside but less conviction than the other firms. Benzinga
• Neutral Sentiment: Market commentary highlighted that Quantinuum has “scored multiple buy ratings,” reinforcing the view that the stock’s move is being driven primarily by analyst optimism around the company’s quantum computing prospects. MSN

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on QNT shares. UBS Group started coverage on shares of Quantinuum in a report on Monday. They set a “buy” rating and a $93.00 price objective for the company. JPMorgan Chase & Co. started coverage on shares of Quantinuum in a research note on Monday. They set an “overweight” rating and a $97.00 target price for the company. Jefferies Financial Group started coverage on Quantinuum in a research note on Monday. They issued a “buy” rating and a $90.00 price target on the stock. Bank of America started coverage on Quantinuum in a report on Monday. They issued a “buy” rating and a $100.00 price objective for the company. Finally, Cantor Fitzgerald initiated coverage on Quantinuum in a research report on Monday. They set an “overweight” rating and a $90.00 price objective for the company. Three equities research analysts have rated the stock with a Strong Buy rating, nine have issued a Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus target price of $98.75.

About Representative FIELDS

Cleo Fields (Democratic Party) is a member of the U.S. House, representing Louisiana’s 6th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Fields (Democratic Party) is running for re-election to the U.S. House to represent Louisiana’s 6th Congressional District. He declared candidacy for the primary scheduled on November 3, 2026.

Cleo Fields graduated from McKinley High School in 1980. He earned a bachelor’s degree in mass communications from Southern University in 1984 and a J.D. from the Southern University Law Center in 1987. His career experience includes working as a state legislator and U.S. congressman. When Fields was elected to the Louisiana State Senate in 1986, he was the youngest person ever elected to the State Senate in Louisiana’s history. In 1995, Fields ran for governor of Louisiana, becoming the first African American since reconstruction to make the runoff.

About Quantinuum

Quantinuum is a quantum computing company focused on developing hardware and software for commercial and scientific applications. The company provides access to its quantum systems, along with software tools and services designed to help customers explore use cases in areas such as optimization, materials science, chemistry, cybersecurity, and machine learning.

The company was formed through the combination of Honeywell Quantum Solutions and Cambridge Quantum in 2021. Quantinuum operates internationally and serves a range of customers across enterprise, government, and research markets.